Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale

Schizophrenia Research
A George Awad, Lakshmi N P Voruganti

Abstract

This report describes the development of a new questionnaire designed to capture and quantify the psychosocial impact of weight gain associated with psychotropic drug use, and presents results of a preliminary validation study. Based on a review of literature, consultations with experts, interviews with individual patients and focus groups, themes relevant to weight gain and its psychosocial consequences were identified. A 12-item self-report questionnaire was designed and administered to a heterogeneous group of psychiatric outpatients (n = 141) receiving antipsychotic and other adjunctive medications. The scale could be self-administered in 2-3 min with minimal assistance. Correlational analysis showed a high internal consistency (Cronbach's alpha 0.79) and fair split half reliability (Spearman-Brown coefficient of 0.76). The total scores were able to distinguish groups of people with higher and lower body mass index (BMI) (chi(2) = 16.4, p < 0.001), suggestive of good discriminant validity. Repeated administration of the scale in 56 subjects on 2 occasions with a gap of 1 week in between revealed a test-retest reliability coefficient of 0.81 (p < 0.001). These preliminary findings indicate that body weight, image and self-es...Continue Reading

References

May 1, 1979·Psychological Medicine·D M Garner, P E Garfinkel
Jan 1, 1982·Addictive Behaviors·J GormallyD Rardin
May 16, 2000·The Journal of Clinical Psychiatry·G L Blackburn
Mar 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·David B AllisonDiana D McDonnell

❮ Previous
Next ❯

Citations

Feb 1, 2012·Eating and Weight Disorders : EWD·R Bou KhalilS Richa
Sep 11, 2014·Health Promotion International·Ron Shor, Anat Shalev
Mar 2, 2010·Schizophrenia Research·Kelly P Arbour-NicitopoulosTony A Cohn
Nov 8, 2006·Suicide & Life-threatening Behavior·Adrian C North, David J Hargreaves
Sep 26, 2006·Schizophrenia Research·Marc De HertJoseph Peuskens
Mar 25, 2014·The International Journal of Lower Extremity Wounds·Yao HuangHong Ruan
Apr 14, 2006·Current Opinion in Psychiatry·David J Castle, Susan L Rossell
Jan 24, 2012·PharmacoEconomics·A George Awad, Lakshmi N P Voruganti
Jul 22, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·M De HertJ Peuskens
Oct 15, 2011·The Patient·John F P BridgesAxel Mühlbacher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.